RPS disputes NICE appraisal of pharmacist medication reviews

摘要

The Royal Pharmaceutical Society (RPS) has disputed a proposed guideline from the National Institute for Health and Care Excellence (NICE) that says pharmacist-led medication reviews are "not cost effective" for the health service. The economic assessment outlined in a draft clinical guideline on medicines optimisation, is not in line with evidence of the benefits to patients seen in current pharmacy practice, the RPS said.